| Date Checked | 2025-12-21 23:44:11 |
|---|---|
| Graham Number | (PB)17.82 vs (PE)33.06 |
| Over / Under Value Percentage | 153.99% vs 68.51% |
| Dividend Yield | 3.45% |
| Dividend Date | 2026-01-08 |
| Symbol | GSK |
| AssetType | Common Stock |
| Name | GlaxoSmithKline PLC ADR |
| Description | GlaxoSmithKline PLC (GSK) is a leading global biopharmaceutical company based in Brentford, UK, focused on enhancing health outcomes through its pioneering pharmaceuticals, vaccines, and consumer healthcare offerings. With a strong emphasis on research and development, GSK addresses critical global health challenges and maintains a diversified portfolio across key therapeutic areas. The company’s strategic commitment to innovation and sustainability not only positions it as a prominent player in the healthcare sector but also presents compelling investment opportunities for institutional investors looking to engage with the dynamic biopharmaceutical industry. |
| CIK | 1131399 |
| Exchange | NYSE |
| Currency | USD |
| Country | USA |
| Sector | HEALTHCARE |
| Industry | DRUG MANUFACTURERS - GENERAL |
| Address | 79 NEW OXFORD STREET, LONDON, UNITED KINGDOM, WC1A 1DG |
| OfficialSite | https://www.gsk.com |
| FiscalYearEnd | December |
| LatestQuarter | 2025-09-30 |
| MarketCapitalization | 98041512000 |
| EBITDA | 9519000000 |
| PERatio | 13.8 |
| PEGRatio | 0.428 |
| BookValue | 4.011 |
| DividendPerShare | 0.64 |
| EPS | 3.52 |
| RevenuePerShareTTM | 15.82 |
| ProfitMargin | 0.171 |
| OperatingMarginTTM | 0.326 |
| ReturnOnAssetsTTM | 0.0713 |
| ReturnOnEquityTTM | 0.415 |
| RevenueTTM | 32166001000 |
| GrossProfitTTM | 23299000000 |
| DilutedEPSTTM | 3.52 |
| QuarterlyEarningsGrowthYOY | 0.232 |
| QuarterlyRevenueGrowthYOY | 0.067 |
| AnalystTargetPrice | 49.35 |
| AnalystRatingStrongBuy | 1 |
| AnalystRatingBuy | 1 |
| AnalystRatingHold | 5 |
| AnalystRatingSell | 1 |
| AnalystRatingStrongSell | 0 |
| TrailingPE | 13.8 |
| ForwardPE | 9.62 |
| PriceToSalesRatioTTM | 3.048 |
| PriceToBookRatio | 4.631 |
| EVToRevenue | 2.75 |
| EVToEBITDA | 8.19 |
| Beta | 0.231 |
| 52WeekHigh | 49.31 |
| 52WeekLow | 30.41 |
| 50DayMovingAverage | 45.27 |
| 200DayMovingAverage | 40.24 |
| SharesOutstanding | 2018561000 |
| SharesFloat | 3900630000 |
| PercentInsiders | 0.061 |
| PercentInstitutions | 19.123 |
| ExDividendDate | 2025-11-14 |
| etoro | 1 |
| dateChecked | 2025-12-21 23:44:11 |
| fresh | 1 |